Waters Corporation
United States
About Waters Corporation
379 articles about Waters Corporation
-
Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns
4/22/2024
Waters Corporation introduced new GTxResolve Premier Size Exclusion Chromatography 1000Å 3-micron Columns.
-
Waters Corporation Schedules First Quarter 2024 Earnings Conference Call
4/11/2024
Waters Corporation (NYSE:WAT) will hold its Q1 2024 financial results conference call live on Tuesday, May 7th, 2024 at 8:00 a.m. Eastern Time.
-
Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors
4/9/2024
Waters Corporation announced the launch of the Alliance iS Bio HPLC System with new capabilities that address the operational and analytical challenges of biopharma quality control laboratories.
-
Waters Advances Battery Electrode Design and Performance Analysis with New Rheo-IS Accessory
3/13/2024
Waters Corporation announced a new accessory for its TA Instruments Discovery Hybrid Rheometers designed to enable simultaneous electrical impedance and rheological measurements, a critical capability for scientists working on new battery formulations.
-
Despite the changing landscape in biopharma, many companies are still recruiting. If you’re looking to make a career change, here are 12 biopharma companies hiring on BioSpace now.
-
Waters Announces Seamless HPLC/UPLC Data Bridge for Light Scattering, Integrating Essential Instruments for Large Molecule Characterization
2/26/2024
Waters Corporation announced HPLC CONNECT software, an all-in-one software platform that enables full digital synchronization between Waters high- and ultra-performance liquid chromatography systems and multi-angle light-scattering instruments from its Wyatt Technology™ portfolio.
-
Waters Corporation to Present at the TD Cowen 44th Annual Health Care Conference
2/22/2024
Waters Corporation announced that Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the TD Cowen 44th Annual Health Care Conference on Monday, March 4th, 2024 at 11:10AM Eastern Time
-
Waters Corporation Schedules Fourth Quarter 2023 Earnings Conference Call
1/18/2024
Waters Corporation (NYSE:WAT) will hold its Q4 2023 financial results conference call live on Tuesday, February 6th, 2024 at 8:00 a.m. Eastern Time.
-
Waters Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
12/21/2023
Waters Corporation announced that Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 8, 2024 at 7:30PM Eastern Time.
-
Waters Corporation Board of Directors Named 2024 Public Company Board of the Year by National Association of Corporate Directors New England Chapter
12/18/2023
Waters Corporation announced that its Board of Directors has been named 2024 "Public Company Board of the Year" by the National Association of Corporate Directors New England Chapter.
-
Waters Accelerates Oligonucleotide Bioanalysis with the Launch of OligoWorks™ SPE Workflow and Kits
10/19/2023
Waters Corporation announces the launch of OligoWorks™ SPE Kits and components to improve sample preparation for LC-MS-based bioanalytical quantitation of therapeutic oligonucleotides.
-
Waters ZetaStar Instrument Boosts Speed and Sensitivity of Light Scattering Measurements for Biological Therapies
9/20/2023
Waters Corporation introduces the DynaPro™ ZetaStar™ instrument from its Wyatt Technology™ portfolio for nanoparticle analysis.
-
Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media
9/12/2023
Waters Corporation announced new bioprocess walk-up solutions designed to further simplify biologic sample prep and analysis.
-
Waters Corporation to Present at the Bank of America Global Healthcare Conference 2023
8/30/2023
Waters Corporation announced that Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Bank of America Global Healthcare Conference in London on Wednesday, September 13th, 2023 at 8:20AM Eastern Time
-
Waters Corporation and Princeton University Announce Multi-Year Research Collaboration
6/26/2023
Waters and Princeton University signed a multi-year agreement to take on real-world challenges in biologics and materials research.
-
Waters Boosts Resolution and Triples Scan Speed of SELECT SERIES MRT for Metabolomics and MS Imaging
6/5/2023
Waters Corporation announced new updates to its SELECT SERIES™ MRT System that increases its specificity and utility for UPLC-MS/MS metabolomics and drug discovery applications and for mass spectrometry imaging experiments.
-
Waters Takes Targeted, Quantitative Imaging to the Next Level with New DESI Source for the Xevo TQ Absolute System
6/5/2023
Waters Corporation launched the industry's first targeted imaging mass spectrometer based on its Xevo™ TQ Absolute tandem quadrupole mass spectrometer, the most sensitive and compact mass spectrometer in its class.
-
Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing
6/5/2023
Waters Corporation and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biomanufacturing, expanding their joint agreement that began with upstream bioprocessing analytics.
-
Waters Corporation to Present at the Jefferies 2023 Healthcare Conference
5/23/2023
Waters Corporation announced that Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference in New York City on Thursday, June 8th, 2023 at 9:30AM Eastern Time.
-
Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology
5/16/2023
Waters™ Corporation announced it has completed its acquisition of Wyatt Technology, a pioneer and well-recognized leader in innovative light scattering and field-flow fractionation instruments, software, accessories, and services.